Danaher Co. (NYSE:DHR) Holdings Reduced by Beacon Investment Advisory Services Inc.

Beacon Investment Advisory Services Inc. trimmed its holdings in Danaher Co. (NYSE:DHR) by 2.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 156,947 shares of the conglomerate’s stock after selling 4,739 shares during the quarter. Danaher comprises about 1.8% of Beacon Investment Advisory Services Inc.’s portfolio, making the stock its 13th biggest holding. Beacon Investment Advisory Services Inc.’s holdings in Danaher were worth $43,634,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in DHR. HBW Advisory Services LLC acquired a new stake in Danaher during the second quarter valued at approximately $216,000. Mather Group LLC. boosted its stake in shares of Danaher by 155.8% during the 2nd quarter. Mather Group LLC. now owns 8,182 shares of the conglomerate’s stock worth $2,043,000 after acquiring an additional 4,984 shares in the last quarter. Lynx Investment Advisory acquired a new position in shares of Danaher in the 2nd quarter worth $63,000. Eastover Investment Advisors LLC raised its holdings in Danaher by 5.0% during the 2nd quarter. Eastover Investment Advisors LLC now owns 5,455 shares of the conglomerate’s stock worth $1,311,000 after buying an additional 262 shares during the period. Finally, Harbor Capital Advisors Inc. lifted its stake in Danaher by 8.3% during the second quarter. Harbor Capital Advisors Inc. now owns 11,505 shares of the conglomerate’s stock valued at $2,875,000 after buying an additional 879 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of DHR opened at $239.69 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm has a market cap of $173.12 billion, a PE ratio of 45.74, a PEG ratio of 4.41 and a beta of 0.85. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70. The firm’s 50 day moving average price is $254.59 and its 200 day moving average price is $259.41.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.02 EPS. As a group, research analysts expect that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Royal Bank of Canada dropped their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. TD Cowen lifted their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Evercore ISI increased their target price on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research report on Thursday, October 31st. Finally, Stephens reissued an “overweight” rating and set a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.